Why should cannabis professionals attend Latin America’s premier cannabis event in Buenos Aires?
Latin America’s premier cannabis event returns to Buenos Aires, bringing together medical cannabis professionals, industrial hemp producers, and cannabis industry leaders for three days of education, networking, and business development at the heart of Argentina’s evolving cannabis market.
Argentina’s cannabis landscape has transformed dramatically since 2024. The dissolution of ARICCAME shifted licensing authority to provincial governments, creating a patchwork of emerging opportunities for producers who understand regional dynamics. With REPROCANN serving approximately 300,000 authorized patients and medical cannabis projected to grow at 24.8% CAGR through 2030, this conference arrives at a decisive moment for the entire region.
“
Argentina’s domestic cannabis market is projected to generate US$500 million in revenue from hemp and medical cultivation.
— Respect My Region, 2025Whether you’re seeking provincial licensing opportunities, exploring partnerships with Argentine patient associations, or evaluating seed-to-sale technology for ANMAT compliance, Expo Cannabis Argentina brings together the decision-makers shaping the future of Latin American cannabis operations under one roof.
Expo Cannabis Argentina 2026 at a Glance 🇦🇷
Dates October 16-18, 2026
Location Centro Costa Salguero, Buenos Aires, Argentina
Exhibition Scale 400+ cannabis-related stands across multiple pavilions
Audience Type B2B + Consumer (mixed)
Venue Address Av. Costanera Rafael Obligado 1221, Palermo
Official Website expocannabis.com.ar
Confirmed Last verified: January 3, 2026
Buenos Aires
34.60°S 58.38°W Who Should Attend Expo Cannabis Argentina
Expo Cannabis Argentina attracts decision-makers across the cannabis supply chain who are evaluating Latin American market entry or seeking to expand existing operations in Argentina’s rapidly growing medical cannabis sector.
Commercial cultivators seeking LATAM market entry and provincial licensing guidance
Extraction and processing professionals targeting GMP-compliant CBD production
Compliance teams navigating Resolution 1780/2025 and provincial requirements
Investors and business development executives exploring LATAM partnerships
Technology and equipment vendors serving Argentina’s 300,000+ medical patients
Regulatory professionals navigating post-ARICCAME decentralized licensing
Why Expo Cannabis Argentina Matters in 2026
Argentina’s cannabis landscape has transformed dramatically since 2024. The dissolution of ARICCAME (the national cannabis regulatory agency) in 2025 shifted licensing authority to provincial governments, creating a patchwork of emerging opportunities for producers who understand regional dynamics. Provinces like Jujuy, Santa Fe, and Chaco are now leading the way with distinct approaches to implementing Law 27.669.
The numbers tell a compelling story: Argentina’s REPROCANN registry has grown to approximately 300,000 authorized medical cannabis patients, with another 100,000+ applications in the processing queue. Resolution 1780/2025 extended patient permits to three years while tightening requirements for cultivators and NGOs, signaling the government’s commitment to sustainable patient access alongside stricter commercial oversight.
Argentina’s cannabis market is projected to reach US$142.66 million in 2025, with medical cannabis growing at 24.8% CAGR through 2030. LATAM markets are expected to hit US$18 billion by 2030.
Statista & Cognitive Market Research, 2025Planning Your Expo Cannabis Argentina Trip
Whether you’re attending for the first time or returning to expand your LATAM network, these practical tips will help you maximize your conference experience.
🏨 Accommodation
- Book 8-10 weeks in advance – October is springtime in Buenos Aires
- Palermo Hollywood and Palermo Soho offer walkable dining and nightlife
- Recoleta provides upscale hotels, 15-minute taxi to venue
- Puerto Madero waterfront business district is another strong option
📆 Schedule Overview
- Event operates 10:00 AM – 8:00 PM daily across three days
- Four main tracks: Health, Industry, Cultivation, Culture
- 6th National Scientific Poster Contest on Cannabis
- Medical/veterinary consultations and networking receptions
✈️ Getting There
- Ezeiza International (EZE) is the main international hub
- Taxi or rideshare from most BA neighborhoods (20-30 min to venue)
- Bus lines run along Avenida Libertador near the venue
- Venue: Av. Costanera Rafael Obligado 1221, Palermo district
🎪 If You’re Exhibiting
- Stand bookings managed via Google Form on official website
- Review provincial licensing requirements for your product category
- Prepare Spanish-language marketing materials and documentation
- Bring GMP certificates and product COAs for buyer meetings
Understanding Argentina’s Cannabis Regulatory Landscape
Key Regulatory Topics at Expo Cannabis Argentina
- Law 27.669 (2022): Established commercial framework for medical cannabis and industrial hemp (THC <=1%), now implemented at provincial level
- REPROCANN Registry: ~300,000 authorized medical patients with 100,000+ applications pending; 3-year permits for patients
- Resolution 1780/2025: Extended patient permits to 3 years, shortened NGO/caregiver permits to 1 year with stricter documentation
- Provincial Licensing: ~40 hemp licenses issued nationwide by mid-2025; Jujuy’s Cannava S.E. leads with 80-ton annual capacity
Argentina operates as Latin America’s second-largest cannabis market with a unique decentralized regulatory model. Following ARICCAME’s dissolution in 2025, provincial governments now issue cultivation and production licenses. International companies must partner with entities having majority national capital and meeting gender representation requirements under Law 27.669.
Related: Argentina Cannabis Licensing Requirements🇦🇷 Understanding Argentina’s REPROCANN System
Argentina’s cannabis regulatory framework operates through a unique combination of federal legislation and provincial implementation. Understanding REPROCANN, Law 27.350, and Law 27.669 is essential for any serious business engagement at Expo Cannabis Argentina 2026.
Key Facts for Expo Cannabis Argentina Attendees
- ✓ 300,000+ Patients: Argentina’s REPROCANN registry serves approximately 300,000 authorized medical cannabis patients
- ✓ 100,000+ Pending: Over 100,000 patient applications are currently in the processing queue
- ✓ Law 27.350 (2017): Legalized medical cannabis and scientific research, creating the REPROCANN patient registry
- ✓ Law 27.669 (2022): Established commercial framework for medical cannabis and industrial hemp with THC <=1%
- ✓ Cannava S.E. (Jujuy): State-owned cannabis company with ANMAT-authorized 80-ton annual production capacity
- ✓ Provincial Licensing: ~40 hemp licenses issued nationwide by mid-2025 following ARICCAME dissolution
- ✓ Fallo Arriola (2009): Supreme Court decriminalized private adult cannabis possession for personal use
Did You Know?
Argentina’s REPROCANN registry has grown from just thousands of patients in 2020 to approximately 300,000 authorized users in 2025. Resolution 1780/2025 extended individual patient permits to three years while tightening requirements for cultivators and NGOs – a signal that the government is prioritizing sustainable patient access alongside stricter commercial oversight.
Actionable Insight for Expo Attendees
With ARICCAME dissolved and licensing now provincial, understanding regional dynamics is critical. Jujuy leads with Cannava S.E., Santa Fe excels in genetics research through CIDCam, and Chaco formally adopted Law 27.669 in October 2025. International companies should focus on partnerships with entities meeting Law 27.669’s priority criteria: majority national capital and 50%+ women/trans representation in decision-making positions.
Note: Laws and enforcement can change. This information is for educational purposes only.
Operational Challenges Facing Argentine Cannabis Operators
Cannabis businesses entering the Argentine market encounter operational complexities that require significant planning and partnership development. Conference attendees frequently discuss these common challenges:
-
Decentralized Provincial Licensing
Following ARICCAME’s dissolution, each province implements Law 27.669 differently – Jujuy, Santa Fe, and Chaco each have distinct approaches requiring local expertise
-
Priority Licensing Criteria
Law 27.669 prioritizes entities with majority national capital and 50%+ women/trans representation in decision-making positions – international companies must structure partnerships accordingly
-
ANMAT Pharmaceutical Oversight
ANMAT regulates cannabis-based pharmaceutical products, import permits, and GMP compliance – products like Convupidiol and Kanbis required extensive approval pathways
-
Resolution 1780/2025 Compliance
New documentation and traceability requirements for all permit holders, with mandatory re-registration within six months and automatic revocation for non-compliance
What to Prepare Before Expo Cannabis Argentina
Maximize your conference ROI by arriving prepared. Use this checklist to ensure you’re ready to make the most of every networking opportunity and business meeting.
Documents to Bring
- GMP certificates for ANMAT-regulated discussions
- Product certificates of analysis (THC/CBD content)
- Company registration documents for joint ventures
- Export license documentation for LATAM opportunities
- Spanish-language product specifications
- Business cards in both Spanish and English
Questions to Ask Partners
- What provincial licenses do you currently hold?
- How are you navigating Resolution 1780/2025 compliance?
- What is your pharmaceutical-grade CBD production capacity?
- Do you work with cannabis social clubs or patient associations?
- What seed genetics are you developing for Argentine climate?
- What is your REPROCANN patient network reach?
What to Compare
- Extraction equipment (solvent vs. CO2 systems)
- Seed genetics optimized for Argentine growing conditions
- Compliance software for provincial requirements
- ANMAT-compliant pharmaceutical packaging
- Greenhouse/indoor cultivation systems
- Provincial licensing consultants and partners
Frequently Asked Questions
Common questions from cannabis professionals planning to attend Expo Cannabis Argentina.
Is Expo Cannabis Argentina B2B only or open to the general public?
Expo Cannabis Argentina is open to both industry professionals and the general public. The event features family-friendly zones, cultural programming, and educational content alongside professional networking and business tracks. Children under 10 enter free, and seniors receive discounts.
Can international attendees participate in Expo Cannabis Argentina?
Yes, international attendees are welcome at Expo Cannabis Argentina. The event attracts cannabis professionals from across Latin America and beyond. Note that while you can attend the expo and conduct business discussions, Argentina’s REPROCANN medical cannabis program is restricted to residents with proper registration.
What is the refund policy for Expo Cannabis Argentina tickets?
Ticket sales are managed through Ticketek Argentina (ticketek.com.ar). Refund policies vary by ticket type and timing. Contact the event organizers directly through the official website or Ticketek for specific refund terms before purchasing.
Is there a consumption area at Expo Cannabis Argentina?
Recreational cannabis use remains illegal in Argentina despite decriminalization of private possession (Fallo Arriola). Expo Cannabis Argentina focuses on education, industry networking, and medical access information rather than consumption activities.
Are medical consultations available at the event?
Yes, Expo Cannabis Argentina 2026 features medical and veterinary consultation services on-site. These consultations provide general information about therapeutic cannabis use and the REPROCANN registration process.
What languages are spoken at Expo Cannabis Argentina?
Spanish is the primary language at Expo Cannabis Argentina. While many industry professionals and exhibitors speak English, prepare for Spanish-language signage, presentations, and materials. Consider arranging translation support for important business meetings.
Software Solutions for Argentine Cannabis Compliance
For companies entering Argentina’s medical cannabis market or expanding existing operations, compliance software designed for regulated cannabis environments provides essential infrastructure. GrowerIQ’s seed-to-sale tracking platform supports the traceability requirements increasingly expected by provincial regulators and ANMAT.
Key capabilities include lot tracking from cultivation through dispensing, GMP documentation workflows for ANMAT inspections, quality control and batch management for pharmaceutical-grade production, and multi-language interface supporting Spanish operations across Latin American jurisdictions.
Ready to Simplify Your Cannabis Compliance?
See how cannabis facilities in Latin America use GrowerIQ to manage seed-to-sale traceability and regulatory reporting.
Request Demo
About GrowerIQ
GrowerIQ is a complete cannabis production management platform. Ours is the first platform to integrate your facility systems, including sensors, building controls, QMS, and ERP, into a single simplified interface.
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.